TABLE 2. Estimated percent of active1 and inactive2 asthma status among adults3 ever diagnosed with asthma by state/territory - BRFSS Asthma Call-back Survey Land Line And Cell Phone Combined Sample, United States, 2012

State/Territory Sample
size±
Active Inactive
Sample
size
% SE§ 95% CI Sample
size
% SE 95% CI
California 504 388 74.8 3.0 (68.9 – 80.7) 116 25.2 3.0 (19.3 – 31.1)
Hawaii 363 243 59.2 4.9 (49.6 – 68.8) 120 40.8 4.9 (31.2 – 50.4)
Illinois 288 234 70.6 5.3 (60.2 – 81.0) 54 29.4 5.3 (19.0 – 39.8)
Indiana 440 364 78.7 2.6 (73.6 – 83.8) 76 21.3 2.6 (16.2 – 26.4)
Iowa 319 243 69.2 3.8 (61.8 – 76.6) 76 30.8 3.8 (23.4 – 38.2)
Michigan 718 606 81.3 2.2 (77.0 – 85.6) 112 18.7 2.2 (14.4 – 23.0)
Mississippi 409 323 76.9 3.3 (70.4 – 83.4) 86 23.1 3.3 (16.6 – 29.6)
Missouri 374 301 73.4 4.3 (65.0 – 81.8) 73 26.6 4.3 (18.2 – 35.0)
Montana 390 306 73.3 4.2 (65.1 – 81.5) 84 26.7 4.2 (18.5 – 34.9)
Nebraska 895 670 74.2 2.2 (69.9 – 78.5) 225 25.8 2.2 (21.5 – 30.1)
Nevada 227 182 82.1 3.5 (75.2 – 89.0) 45 17.9 3.5 (11.0 – 24.8)
New Hampshire 396 318 78.4 3.3 (71.9 – 84.9) 78 21.6 3.3 (15.1 – 28.1)
New Mexico 467 393 78.3 3.0 (72.4 – 84.2) 74 21.7 3.0 (15.8 – 27.6)
New York 266 215 80.4 4.6 (71.4 – 89.4) 51 19.6 4.6 (10.6 – 28.6)
Ohio 524 454 85.1 2.5 (80.2 – 90.0) 70 14.9 2.5 (10.0 – 19.8)
Oklahoma 326 266 77.5 4.0 (69.7 – 85.3) 60 22.5 4.0 (14.7 – 30.3)
Oregon 325 254 74.9 3.6 (67.8 – 82.0) 71 25.1 3.6 (18.0 – 32.2)
Pennsylvania 947 762 75.2 2.3 (70.7 – 79.7) 185 24.8 2.3 (20.3 – 29.3)
Texas 365 273 69.7 4.0 (61.9 – 77.5) 92 30.3 4.0 (22.5 – 38.1)
Vermont 348 289 83.5 2.8 (78.0 – 89.0) 59 16.5 2.8 (11.0 – 22.0)
Washington 732 556 72.0 2.7 (66.7 – 77.3) 176 28.0 2.7 (22.7 – 33.3)
Wisconsin 269 225 80.1 4.3 (71.7 – 88.5) 44 19.9 4.3 (11.5 – 28.3)
22 state total 9,892 7,865 75.9 1.1 (73.7 – 78.1) 2,027 24.1 1.1 (21.9 – 26.3)
Median     76.1       24.0    
Range     59.2-85.1       14.9-40.8    

1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

3 Aged ≥ 18 years

± Landline and cell phone combined sample size excludes “DK/Refused”

§ Standard error

Confidence interval